A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics | Vaccination | JAMA | JAMA Network
[Skip to Navigation]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.153.100.128. Please contact the publisher to request reinstatement.
Views 26,491
Citations 0
Viewpoint
January 6, 2022

A National Strategy for COVID-19 Medical Countermeasures: Vaccines and Therapeutics

Author Affiliations
  • 1Council on Foreign Relations, New York, New York
  • 2The Rockefeller Foundation, New York, New York
  • 3Perelman School of Medicine and The Wharton School, University of Pennsylvania, Philadelphia
JAMA. 2022;327(3):215-216. doi:10.1001/jama.2021.24165
Limit 200 characters
Limit 25 characters
Conflicts of Interest Disclosure

Identify all potential conflicts of interest that might be relevant to your comment.

Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.

Err on the side of full disclosure.

If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.

Not all submitted comments are published. Please see our commenting policy for details.

Limit 140 characters
Limit 3600 characters or approximately 600 words
    ×